Veterinary Pharmaceuticals Market Definition And Segments

Veterinary pharmaceuticals are a class of drugs that are pharmacologically active and used to control, prevent, and treat diseases in animals. They have an effect when administered to animals and are rapidly broken down into active ingredients due to small intestine metabolism. The main types of veterinary pharmaceuticals include veterinary vaccines, veterinary antibiotics, veterinary parasiticides, and other types. Veterinary vaccines provide protection against one or more diseases, which can lower the severity or prevent certain diseases entirely. The routes of administration include oral and other routes of administration for animal types, including companion animals and livestock animals. The vaccines include inactivated vaccines, attenuated vaccines, recombinant vaccines, and others that are provided by various end-users such as veterinary hospitals, veterinary clinics, pharmacies and drug stores. The veterinary pharmaceuticals market covered in this report is segmented – 1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals 2) By Type Of Animal: Livestock, Companion Animals 3) By Type Of Vaccine: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines 4) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administration 5) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores The veterinary pharmaceuticals market size has grown strongly in recent years. It will grow from $32.53 billion in 2023 to $35.05 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increased pet population, the increased overall spending by individuals on pets, the growing penetration of e-commerce platforms promoting online pharmacies, the emerging markets growth, the increasing government initiatives and the increased disease prevalence. The veterinary pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $46.54 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing pet ownership, the increasing population growth, the increasing disposable income, the increasing urbanization, the increasing penetration of pet insurance and the growing government support will drive the market. Major trends in the forecast period include focus on stem cell therapy to treat animals, focus on application of nanotechnology in veterinary medicines to tackle antibiotic resistance, development of chewable tablets, focus on use of telemedicine platforms to reduce the impact of COVID-19, development of advanced vaccines, focus on super-combo parasiticides, use of subunit and virus-like particle (VLP)-based vaccines and focus on strategic partnerships and collaborations.

Rising Disease Prevalence Among Animals Fuels Growth In The Veterinary Pharmaceuticals Market

The increase in the prevalence rate of diseases among animals serves as one of the major drivers for the veterinary pharmaceuticals market. The increase in the incidence of diseases in livestock and companion animals will require medicines to treat the animals for the diseases. For instance, according to the Banfield State of Pet Health Report, the prevalence of diabetes in dogs has increased by 79.7% from 13.1 cases per 10,000 to 23.6 cases whereas the prevalence rate increased by 18% in cats. The increase in the prevalence rate of diseases among animals results in an increased demand for veterinary pharmaceuticals market.

Rising Pet Ownership Fuels Demand For Veterinary Pharmaceuticals

The increasing pet ownership is expected to boost the growth of the veterinary pharmaceuticals market going forward. Pet ownership refers to the legal and ethical responsibility of individuals or households for the care, maintenance, and well-being of domesticated animals, commonly known as pets. As pet ownership increases, there is a growing demand for specialized medications tailored to different species, breeds, and health conditions. This encourages pharmaceutical companies to develop a wider range of products to cater to specific pet health needs. For instance, in October 2023, according to the report published by the American Pet Products Association Inc., a US-based non-profit association, 66% of households in the US owned a type of pet, as compared to 62% in 2022. Dogs were discovered to be owned by 44.5% of American families, while cats were owned by 29% of households in 2022. Therefore, the increasing pet ownership is driving the growth of the veterinary pharmaceuticals market. Major companies operating in the veterinary pharmaceuticals market report are Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, National Meditek, Fartovet Industry Limited, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co,.Ltd., Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd., Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Lamons Laboratories SA, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica,, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, VitOMEK LCC,, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o.,, Bond Vet, trifecta Pharmaceuticals USA LLC., Trifecta Pharmaceuticals USA LLC., Bio-Synthesis Inc., Small Door Veterinary, Fuzzy, Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd.,, Maure, Peru Animal Hospital, Miami County Veterinary Clinic, Cindy Fouts, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Physio Evolution, Herzliya Veterinary Hospital, Oron Veterinary Center, Dr Aviram Ezra – Veterinarian, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Aesthetics Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., M S J Afro Agro Pharmacy, Global Vet (U) Ltd

Lack Of Awareness About Animal Healthcare Poses A Significant Restraint To The Veterinary Pharmaceuticals Market

The veterinary pharmaceuticals market is being restrained by a lack of awareness about animal healthcare. According to the Animal Welfare Act 2006, proper healthcare means the pet should have regular vaccinations, a suitable diet, protection from pain and suffering, suffering and should be free from any kind of disease. According to the PDSA Animal Wellbeing (PAW) UK report, only 38% of people in the UK are aware of this legislation which shows a very less proportion of the population is aware of animal healthcare and acts as a major restraint for the veterinary pharmaceuticals market.

Regulation And Approval For Medical Products

The veterinary pharmaceuticals market is regulated by government agencies such as European Medicines Agency (EMA), USFDA (the US Food and Drug Administration), and others. For instance, the EU agencies require 6 to 12 months to approve veterinary medicinal products. Moreover, it requires all parts of the registration dossier to be submitted together, unlike the US-FDA, which accepts phased submissions. The US-FDA assesses each technical section for 6 months which may be extended to another 6 month cycle if questions or concerns are raised. However, the technical sections’ assessment is done simultaneously, and therefore, the manufacturers should identify the time-consuming steps and plan the work accordingly and estimate the date of approval. Also, the license validity and renewal of the application in the EU region is very difficult upon the existing regulatory policies. Therefore, the manufacturers of veterinary pharmaceuticals should plan well, communicate effectively to minimize the costs and reduce timelines.

Emergence Of Generic Drugs As A Key Trend In The Veterinary Pharmaceuticals Market

The rise of generic drugs for animal care is being seen as the latest trend in the veterinary pharmaceuticals market. The economical nature of generic drugs enables pet lovers to take care of their pets efficiently. The FDA has approved 22 generic animal drugs for cats and dogs, which has increased the adoption of generic drugs by veterinarians. According to a survey conducted on 520 veterinarians by Brakke and Trone Brand Energy Inc., around 80% of the veterinarians confirmed that they are using generic drugs to save the pet owners’ money. However, the lower margin of profit given by generic drug manufacturers compared with the heavy margins of branded drugs needs to be investigated by veterinarians.

Innovative Veterinary Pharmaceutical Products Meeting Unique Pet Health Needs

Major companies operating in the veterinary pharmaceuticals market are developing new products such as molidustat oral suspensions to meet larger customer bases, more sales, and increase revenue. Molidustat oral suspension refers to a medication used for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats. For instance, in September 2023, Elanco Animal Health Incorporated, a US-based pharmaceutical company, launched, Varenzin-CA1 (molidustat oral suspension), the first and only medication to manage non-regenerative anemia in cats with chronic kidney disease (CKD) and received provisional approval from the U.S. Food and Drug Administration (FDA). Varenzin-CA1 has the unique feature of being an innovative needle-free oral suspension solution for cats that can be administered at home without the requirement for in-clinic injections. This is also the first medication for cats to receive expanded conditional approval, a route to the market that promotes the creation of novel therapies and broadens the options for treating animals with unusual conditions, serious or life-threatening illnesses, or illnesses for which there are no effective or available treatments. North America was the largest region in the veterinary pharmaceuticals market in 2023. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in the veterinary pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the veterinary pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain The veterinary pharmaceuticals market consists of sales of biological drugs, biosimilars, monoclonal antibodies, sedatives, and antihistaminic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary pharmaceuticals research report is one of a series of new reports from The Business Research Company that provides veterinary pharmaceuticals statistics, including veterinary pharmaceuticals industry global market size, regional shares, competitors with veterinary pharmaceuticals share, detailed veterinary pharmaceuticals segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmaceuticals industry. This veterinary pharmaceuticals research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary Parasiticides Market Definition

Veterinary parasiticides refer to the class of animal medications that eliminate parasites by inhibiting the activity of acetylcholinesterase to treat pets, livestock, and other animals from diseases caused by helminths, amoeba, ectoparasites, parasitic fungi, protozoa, and other parasites to improve the animals’ health. The main types of veterinary parasiticides are endoparasiticides, ectoparasiticides, and endectocides. Endectocides are medications that are administered directly to hosts to kill endoparasites and ectoparasites, primarily blood-feeding arthropods. The product types include oral liquids, tablets, injectables, sprays, and other products applied on farm animals, and companion animals that are used by R&D facilities, farms, and veterinary clinics.

Veterinary Parasiticides Market Segmentation

The veterinary parasiticides market covered in this report is segmented – 1) By Type: Endoparasiticides, Ectoparasiticides, Endectocides 2) By Product: Oral Liquids, Tablets, Injectables, Sprays, Other Products 3) By Application: Farm Animals, Companion Animals 4) By End Users: R&D Facilities, Farms, Veterinary Clinics

Veterinary Antibiotics Market Definition And Segments

Veterinary antibiotics refer to a class of animal medications that are used to treat infectious disease in animals by killing microorganisms such as bacteria and parasites by inhibiting the growth of their cell walls to fight infections and diseases in animals caused by bacteria and improve the animals' health conditions. The main product types of veterinary antibiotics include anti-parasitic, anti-bacterial, non-steroidal anti-inflammatory drugs, and other products. Non-steroidal anti-inflammatory drugs (NSAIDs) act as a bridge between the production and activity of prostaglandins (enzymes) implicated in inflammation. Approved veterinary NSAIDs are used in companion animal care to reduce the pain and swelling linked with osteoarthritis in dogs and horses. The administration of veterinary antibiotics includes premixes, injections, oral powders, oral solutions, and other administrations used on farm animals and companion animals. The veterinary antibiotics market covered in this report is segmented – 1) By Product: Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others 2) By End User: Farm Animals, Companion Animals 3) By Administration: Premixes, Injections, Oral Powders, Oral Solutions, Others The veterinary antibiotics market size has grown rapidly in recent years. It will grow from $2.2 billion in 2023 to $2.44 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increased pet spending and shortages of generic medicines. factors that negatively affected growth in the historic period were shortages of veterinarians, lack of awareness, inappropriate use of medicines, and stringent regulations. The veterinary antibiotics market size is expected to see strong growth in the next few years. It will grow to $3.56 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing penetration of pet insurance, rise in pet ownership, increase in government initiatives, and growing awareness about animal health. Major trends in the forecast period include strategic collaborations and partnerships, development of new chewable medicines, combination parasiticides, new improved treatments for arthritis and production of generic drugs for animal care.

Rising Zoonotic Disease Threat Spurs Growth In The Veterinary Antibiotics Market

An increase in the number of zoonotic diseases is driving the veterinary antibiotics market. Zoonotic diseases are infectious diseases caused by microscopic organisms, infections, and parasites that spread between animals and humans. Two of the most common zoonotic pathogens, salmonella and campylobacter, are present in the intestines of these animals. Zoonotic diseases are also a potential threat to humans as they get transferred through the food chain. A study conducted by the FoodNet (Centers for Disease Control and Prevention, USA) found that 24,484 foodborne illnesses, 5,677 hospitalizations, and 122 deaths are caused by zoonotic diseases. In addition, the highest incidences per 100,000 people in the USA are caused by infectious diseases such as campylobacter, salmonella, and shigella. Therefore, there is a need to diagnose these diseases in animals at an early stage, which is a major driver of the veterinary antibiotics market.

Growing Pet Ownership To Drive Market Growth

The rising pet ownership rate is expected to propel the growth of veterinary antibiotics market going forward. Pet ownership is the legally recognized and responsible act of having and caring for domesticated animals as companions, which involves providing for their physical, emotional, and medical needs. As the number of pets increases, there will be a rising the demand for antibiotics to treat and prevent illnesses in pets, as more pets create a larger patient base, necessitating veterinary care, including antibiotics, to maintain their health and well-being. For instance, in May 2023, according to North American Pet Health Insurance Association, a US-based trade association, the number of insured pets in North America reached 5.36 million by the end of 2022, reflecting a significant growth of 21.7% from the 4.4 million pets insured in 2021. Therefore, the rising pet ownership rate is driving the growth of veterinary antibiotics market. Major companies operating in the veterinary antibiotics market report are Boehringer Ingelheim GmbH, Zoetis, Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Ceva Santé Animale, Virbac Group, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Dechra Pharmaceuticals PLC, Merck/MSD Animal Health, Bayer Animal Health China, China Animal Healthcare Ltd., China Animal Husbandry Industry Corporation Ltd. (CAHIC), Elanco, Guangdong Wens Dahuanong Biotechnology Co. Ltd., IDEXX Laboratories, Merial Pulike Biological Engineering, Ceva Santé Animale, Nimrod Veterinary Products Ltd., Bimeda, VIRBAC SA, Orion Animal Health, Laboratorios Calier, SA, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Lamons Laboratories SA, SUPER'S DIANA, Swetrade Pharmaceuticals AB, Animalcare, VIC Animal Health, AVZ animal health, Provet Group, VitOMEK LCC, Micro-plus, Biowet, Bioveta, Brovapharma, Evrovet, Ukrvetprompostach, VELELEK d.o.o, Veterinarski Zavod Subotica, VetPlanet, Delos Medica, Vetro Solutions, Belfarmacom, IDT Biologika, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Saudi Pharmaceutical Industries (SPI), DBK Pharma S.A.E., MSD Animal Health South Africa

Antibiotic Resistance Impeding The Growth Of Veterinary Antibiotics Market

The rising threat of antibiotic resistance is a major restraint for the veterinary antibiotics market. Antibiotic resistance in animals refers to the ability of a microbe to withstand the impact of an antibiotic that once successfully treated infections caused by the same type of microbe. This can be a result of using antibiotics more than the prescribed limit. In this regard, the European Union (EU) has approved various restrictions on veterinary antibiotics, including a ban on antibiotics for animals and prohibiting the usage of antimicrobials in food, which is restricting the veterinary antibiotics market growth.

Collaborative Strategies Transforming The Veterinary Antibiotics Market

Increasing collaboration between companies is an emerging trend in the veterinary antibiotics market. Collaboration offers companies the opportunity to combine technologies and a wide range, more diversified products to work with, and it also improves the quality of the antibiotics and the speed at which they are produced. Therefore, companies in the veterinary antibiotics market are focusing on collaborations. For instance, in September 2022, GlobalVetLink, a US-based provider of software services and informatics solutions in the field of animals, collaborated with Veterinary Innovative Partners to install GlobalVetLink Compliance Assistant, a thorough SaaS platform developed to simplify animal health.

Digital Health And Telemedicine Reshaping The Veterinary Antibiotics Market

Major companies operating in the veterinary antibiotics market are developing telemedicine platforms for pet healthcare to gain a competitive edge in the market. Telemedicine is a healthcare practice that involves the remote diagnosis, consultation, treatment, and monitoring of patients using telecommunications technology, such as video conferencing, phone calls, or secure messaging platforms. For instance, in June 2023, Cargill Inc., a US-based food corporation launched Zoonivet, a digital pet-care app. This Telehealth platform simplifies pet healthcare by connecting pet parents with qualified veterinarians through video calls, making primary pet care accessible and convenient. Zoonivet also plans to provide surgery, home diagnostic services, medication, pet food, and pet boarding across key Indian markets.

Regulatory Oversight Of Veterinary Antibiotics Ensuring Responsible Use And Compliance

The veterinary antibiotics prescription drugs market is regulated by Section 503(f) of the Food, Drug, and Cosmetic Act of FDA. According to this law, the veterinary antibiotic drug labels are mandated to include a caution statement that states that these drugs can only be used with the permission of a licensed veterinarian. The sale and use of antibiotic prescription drugs without a prescription is usually reported to the FDA and strict action is taken based on it. Hence, regulations such as these would regulate veterinary antibiotic manufacturers and sellers. North America was the largest region in the veterinary antibiotics market in 2023. Asia-Pacific was the second-largest region in the global veterinary antibiotics market share. The regions covered in the veterinary antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the veterinary antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain The veterinary antibiotics market consists of sales of antivirals, antiprotozoals, antifungals, aminoglycosides, beta-lactams, fluoroquinolones, glycopeptides, and lipopeptides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary antibiotics research report is one of a series of new reports from The Business Research Company that provides veterinary antibiotics statistics, including veterinary antibiotics industry global market size, regional shares, competitors with veterinary antibiotics share, detailed veterinary antibiotics segments, market trends and opportunities, and any further data you may need to thrive in the veterinary antibiotics industry. The veterinary antibiotics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Nutritional Feed Additives Market Definition

Nutritional feed additives various types of products used in animal nutrition to improve the nutritional content and quality of feed, or to improve the health and performance of animals. They help improve the nutritional content and quality of feed, resulting in higher productivity and disease prevention. The main additive types of nutritional feed additives are antibiotics, vitamins, antioxidants, amino acids, enzymes, mycotoxin detoxifiers, prebiotics, probiotics, flavours and sweeteners, pigments, binders, and minerals. Antibiotics are medications that aid in the treatment of bacterial illnesses. They accomplish this by either killing the bacteria or preventing them from replicating or reproducing. The nutritional feed additives are available in various forms, such as dry, liquid, and other forms that are used on ruminants, poultry, swine, and aquatic livestock. The additives are distributed through direct, indirect channels, hypermarkets and supermarkets, specialty stores, and online retail channels.

Nutritional Feed Additives Market Segmentation

The nutritional feed additives market covered in this report is segmented – 1) By Form: Dry, Liquid, Other Forms 2) By Additive Type: Antibiotics, Vitamins, Antioxidants, Amino Acids, Enzymes, Mycotoxin Detoxifiers, Prebiotics, Probiotics, Flavors And Sweeteners, Pigments, Binders, Minerals 3) By Livestock: Ruminants, Poultry, Swine, Aquatic 4) By Distribution Channel: Direct, Indirect, Hypermarket/Supermarket, Specialty Stores, Online Retail

Veterinary Medical Equipment Market Definition And Segments

Veterinary medical equipment refers to types of medical devices and surgical equipment such as endoscopic systems, dental equipment, and veterinary telemetry services that are used for operations, therapy, keeping track of diagnoses and vitals, and enhancing animal care to slow down the progression of diseases. The main types of veterinary medical equipment are veterinary diagnostic equipment, veterinary anesthesia equipment, veterinary patient monitoring equipment, and other veterinary medical equipment. Veterinary diagnostic equipment refers to a range of medical tools and devices used by veterinarians to assess, diagnose, and monitor the health of animals. These types of equipment are used for animals such as small companion animals, large animals, and other animals. The products used are instruments, equipment, and disposables which are used in veterinary hospitals, veterinary clinics, and research institutes. The veterinary medical equipment market covered in this report is segmented – 1) By Type: Veterinary Diagnostic Equipment, Veterinary Anesthesia Equipment, Veterinary Patient Monitoring Equipment, Other Veterinary Medical Equipment 2) By Product: Instruments/Equipment, Disposables 3) By Animal Type: Small Companion Animals, Large Animals, Other Animals 4) By End User: Veterinary Hospitals, Veterinary Clinics, Research Institutes The veterinary medical equipment market size has grown strongly in recent years. It will grow from $2.44 billion in 2023 to $2.61 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increased pet ownership by gen x and gen y adults, increased pet spending, increased disease prevalence. The veterinary medical equipment market size is expected to see strong growth in the next few years. It will grow to $3.45 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to adoption of companion animals, increased efficiency of veterinary treatment with portable x-rays and ultrasound scanners, increased standards of living and strengthened middle class, increasing awareness of pet vaccinations and legal requirement of microchipping. Major trends in the forecast period include veterinary diagnostic providers should consider investing in advance technologies for faster diagnosis of medical condition, rapid adoption of companion animals will drive the market, ultimately growing the veterinary equipment market, veterinary diagnostic service providers should consider adopting molecular biology for early detection of disease, since wearable technologies enable farmers and veterinarians to track critical health parameters in pets and animals, they should consider investing in these technologies, and companies should utilize 3D printers to enable versatility and personalization of veterinary supplies.

Growing Global Economy Boosts The Veterinary Medical Equipment Market

The global economy is expected to go through a continued period of steady growth during the forecast period. The US economy showed steady growth during the historic period, and this is likely to continue during the forecast period. Emerging markets reached 4.8% in 2020 versus 3.6% in 2019. The continued economic growth is expected to contribute to increased standards of living of the global population and strengthen the presence of the middle class. Increased standards of living and a strengthened middle class will further drive the demand for improved nutrition, particularly animal protein, and increase focus on food quality and safety, supporting the growth of the animal medicine market in terms of feed additives. Thus, economic growth is expected to drive this market.

Increasing Incidence Of Animal Diseases Propels The Growth Of The Veterinary Medical Equipment Market

Increasing prevalence of diseases in animals is driving the growth of the veterinary medical equipment market going forward. Animal diseases are impairments of the normal state of an animal that interrupt or modify its vital functions. It can be caused by a variety of factors, including bacteria, viruses, parasites, fungi, and environmental factors. Veterinary medical equipment plays a crucial role in detecting and diagnosing animal diseases. These tools aid veterinarians in understanding the underlying causes of an animal's illness, leading to more effective treatment and management. For instance, in July 2022, according to an article by United Nations Organization, between January 1st and July 8th, 2022, there has been a total of 2,087 reported cases of monkeypox, with only 203 of them being officially confirmed. Among the 203 confirmed cases, the overall case fatality rate stands at 2.4%. Therefore, increasing prevalence of diseases in animals is expected to propel the growth of the veterinary medical equipment market in the forecast period. Major companies operating in the veterinary medical equipment market report are Covetrus Inc., IDEXX Laboratories Inc., Integra LifeSciences Corporation, Mindray Medical International Limited, Midmark Corporation, Smiths Group PLC, Carestream Health, Agfa-Gevaert Group, Nonin Medical, B. Braun Vet Care GmbH, Risol International Industrial Co., Limited, Guangzhou Medsinglong Import & Export Co., Ltd., Arosol Chemicals Private Limited, Applied Bio Diagnostics Private Limited, Zoetis, Elanco, Merck Co. Inc., Vetpak, Agilis Ltd., Eickemeyer, Vetlabsupplies, Burtons, Virbac, Avz Animal Health, Dixion, Vic Group, Vetmarket, Draminski, Chifa, Ogena Solutions, Axiom Medical Inc., Carolina Scales Inc., Cenogenics Corp, Renco Corporation, Gervetusa Veterinary Surgical Instruments, X-Cel X-Ray Corp, Surgitel, Div. Of General Scientific Corp, Spectrum Chemical Mfg. Corp, Boston Medical, Enso Doctors, Medical Coaches Inc., Lab Oratorio Proagro S.A., Vesalius Pharma Ltd., Apilab Srl, Ceba, Centrovet, Hoppner Vet, Instituto Veterinario Uruguay S.A, Interchem Ltda, Boehringer Ingelheim Mena, Saudi Pharmaceutical Industries (Spi), Bimeda Chemicals Limited, DBK Pharma S.A.E., MSD Animal Health South Africa, Ceva Animal Health (Pty) Ltd

Impact Of COVID-19 On The Veterinary Medical Equipment Market

The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the veterinary medical equipment market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and has spread globally, including Western Europe, North America, and Asia. Steps by national governments to contain the transmission have resulted in a decline in economic activity with countries entering a state of lock down and the outbreak hurting businesses throughout 2020 and into 2021. However, it is expected that the veterinary medical equipment market will recover from the shock across the forecast period as it is a black swan event and not related to ongoing or fundamental weaknesses in the market or the global economy.

Enhancing Veterinary Services Through Advanced Diagnostic Tools

Advances in diagnostic tools have improved veterinary services. Equipment such as portable x-ray and portable ultrasound scanners has increased the efficiency of veterinary treatment (especially in emergencies due to injury) for all equine/large animals, companions, exotic and mixed animal practices. For example, Wristscan V9, a diagnostic device, is being used for pregnancy tests for animals. In addition, the Alivecor iPhone app is used to perform electrocardiograms on animals for cardiologist review.

Advanced Vet-Centric Scanning Solutions

Major companies operating in the animal services market are focusing on technological advancements such as Magnifico Vet MRI System to sustain their position. Magnifico Vet MRI System is a new imaging solution that provide diagnostic efficacy in a variety of veterinary hospitals. For instance, in January 2023, Esaote North America, Inc., a US-based animal health technology company, launched Magnifico Vet MRI System which is built for animals of various sizes. The eco-conscious Magnifico Vet utilizes sustainable green permanent-magnet technology which operates without the need for cryogens and consumes substantially less power compared to superconducting systems. It represents a remarkable feat of functional design, poised to provide exceptional diagnostic image quality. North America was the largest region in the veterinary medical equipment market in 2023. Asia-Pacific was the second-largest region in the veterinary medical equipment market. The regions covered in the veterinary medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the veterinary medical equipment market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa The veterinary medical equipment market consists of sales of stethoscopes, ultrasounds, x-ray machines, sonography machines, and intravenous pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary medical equipment research report is one of a series of new reports from The Business Research Company that provides veterinary medical equipment statistics, including veterinary medical equipment industry global market size, regional shares, competitors with veterinary medical equipment shares, detailed veterinary medical equipment segments, market trends and opportunities, and any further data you may need to thrive in the veterinary medical equipment industry. This veterinary medical equipment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary Healthcare Market Definition

Veterinary healthcare refers to a healthcare service that is associated with the diagnosis, treatment, and prevention of diseases in animals and the duties of an individual whose job it is to provide medical care for animals who are ill or injured, or to describe such care to reduce transmission of infectious disease from one pet to another. The main types of veterinary healthcare are veterinary services, veterinary medical equipment, animal medicine and are used for the animals such as dogs and cats, horses, ruminants, swine, poultry, and other animals. Veterinary services refer to the healthcare services that are provided to the animals. The products include instruments/equipment, disposables.

Veterinary Healthcare Market Segmentation

The veterinary healthcare market covered in this report is segmented – 1) By Type: Veterinary Services, Veterinary Medical Equipment, Animal Medicine 2) By Animal Type: Dogs and Cats, Horses, Ruminants, Swine, Poultry, Other Animals 3) By Product: Instruments/Equipment, Disposables Subsegments Covered: Animal Hospitals And Veterinary Clinics, Veterinary Laboratory Testing Services, Veterinary Diagnostic Equipment, Veterinary Anesthesia Equipment, Veterinary Patient Monitoring Equipment, Other Veterinary Medical Equipment, Veterinary Pharmaceuticals, Feed Additives

Veterinary Services Market Definition And Segments

Veterinary services refer to a type of service that is engaged in providing veterinary services to pets, farm animals, and animals kept in zoos and wildlife parks, including animal hospitals and veterinary clinics that provide consultation services, treatment, and curative medicines to animals to improve their health and life cycles. The main types of veterinary services are animal hospitals and veterinary clinics, and veterinary laboratory testing services. Veterinary laboratory testing services refer to the services that are provided to animals to test for a disease. The types of services offered are onsite and offsite and are used for livestock and companion animals. The expenditure includes public and private. The veterinary services market covered in this report is segmented – 1) By Type: Animal Hospitals And Veterinary Clinics, Veterinary Laboratory Testing Services 2) By Type of Service: Onsite, Offsite 3) By Type of Animal: Livestock, Companion Animals 4) By Type of Expenditure: Public, Private Subsegments Covered: Routine Examinations, Non-surgical Procedures, Surgical Procedures, Pet Animals Laboratory Testing Services, Livestock Laboratory Testing Services The veterinary services market size has grown strongly in recent years. It will grow from $138.94 billion in 2023 to $148.77 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the growth of pet ownership trends, humanization of pets, urbanization and population density, and companion animal insurance. The veterinary services market size is expected to see strong growth in the next few years. It will grow to $194.28 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to preventive and wellness services, specialized veterinary care, one health approach, e-commerce in pet pharmaceuticals, and global pandemic impact. Major trends in the forecast period include technological innovations, telemedicine and remote consultations, advancements in veterinary medicine, telehealth for pets, and a focus on preventive care.

Rising Meat Production Fuels Growth In Veterinary Services Market

Global meat production is expected to rise in the forecast period, supporting the growth of the veterinary services market. According to the US Department of Agriculture, in 2020, beef production in the USA increased to 27.5 billion pounds, the highest production volume registered in the country. Rising meat production is especially prominent in developing countries such as China, India, and Brazil, where increasing populations and rising income levels are stimulating the demand for meat products. By 2027, the production of meat and poultry in emerging markets is expected to increase by 76%. By 2050, China's meat imports are expected to grow by over 3,500% to $150 billion as consumption of chicken, pork, and beef will surge due to the country's rising middle class. The rising production of meat products supported by the growing population will increase the demand for feed additives in the livestock industry, driving the veterinary services market.

Companion Animal Adoption Fuels Veterinary Services Market Growth

The rising adoption of companion animals is expected to drive the growth of the veterinary services market. Companion animals refer to domesticated or domestic-bred animals whose physical, emotional, behavioral, and social needs are quickly addressed as housemates or near humans. Veterinary services are essential for diagnosing and treating health issues in companion animals, ensuring their well-being, and preventing the spread of zoonotic diseases. For instance, in June 2023, according to the American Pet Products Association, a US-based trade association representing the pet industry, Americans spent $136.8 billion on pet health in 2022, an increase of 10.68% from $123.6 billion in 2021. Therefore, the rising adoption of companion animals is driving the growth of the veterinary services market. Major companies operating in the veterinary services market report are Mars Inc., Zoetis Inc., VCA Inc., IDEXX Laboratories Inc., Qiagen N.V., Pets at Home Group PLC, BluePearl Pet Hospital, Dechra Pharmaceuticals PLC, PetIQ LLC, CVS Group PLC, Banfield Pet Hospital, Neogen Corporation, Vetpartners, Greencross Limited, National Veterinary Associates Inc., Pathway Vet Alliance LLC, Ethos Veterinary Health LLC, Southern Veterinary Partners, VetCor, VetStrategy, National Veterinary Care Ltd., VetnCare, PetVet Care Centers, Kremer Veterinary Services, Armor Animal Health, Addison Biological Lab Inc., FirstVet AB, Vetnovo

Impact Of COVID-19 On The Veterinary Services Market

The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the veterinary services market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and has spread globally, including Western Europe, North America, and Asia. Steps by national governments to contain the transmission have resulted in a decline in economic activity with countries entering a state of ‘lockdown’ and the outbreak hurting businesses throughout 2020 and into 2021. However, it is expected that the veterinary services market will recover from the shock across the forecast period as it is a ‘black swan’ event and not related to ongoing or fundamental weaknesses in the market or the global economy.

The Growing Use Of Telemedicine In Veterinary Care

Telemedicine is gaining traction as this technology enables pet owners to get access to quality care from remote locations. Telemedicine is a subset of telehealth that includes remote clinical and non-clinical elements of the healthcare system. It refers to the direct communication between veterinarians and clients via communication systems such as phones, mail, and video conferencing technologies. This technology also helps in improving existing veterinarian-client-patient relationships. Busy lifestyles and consumers' preference for personalized services are driving the demand for telemedicine services. For instance, some of the veterinary clinics offering telemedicine include Televet, Fuzzy Pet Health, and Healthpets.

Strategic Partnerships To Gain A Competitive Edge

Major companies operating in the veterinary services market are focused on developing strategic partnerships to drive revenues in the market. Collaboration between companies can bring several advantages, including access to new technology, increased customer choice, global servicing capabilities, a collaborative global platform, and integration of services. For instance, in September 2022, GlobalVetLink, a US-based provider of software services and informatics solutions in the field of animals, collaborated with Veterinary Innovative Partners to streamline clinic processes. By implementing the GlobalVetLink Compliance Assistant platform, Veterinary Innovative Partners aims to improve efficiency in managing animal health certificates and other compliance documents required for pet travel. The GlobalVetLink Compliance Assistant is a comprehensive Software-as-a-Service (SaaS) platform designed to streamline animal health compliance for all veterinary practices. North America was the largest region in the veterinary services market in 2023. Asia-Pacific was the second-largest region in the veterinary services market. The regions covered in the veterinary services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary services market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa. The veterinary services market includes revenues earned by entities by providing treatment for ill animals, prevention of production-limiting conditions, distribution of medicines, vaccinations, and other products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary services research report is one of a series of new reports from The Business Research Company that provides veterinary services statistics, including veterinary services industry global market size, regional shares, competitors with veterinary services share, detailed veterinary services segments, market trends and opportunities, and any further data you may need to thrive in the veterinary services industry. This veterinary services research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.